Testing effectiveness (Phase 2)Active Not RecruitingNCT06628362
What this trial is testing
Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Who this might be right for
Overweight or ObeseType 2 Diabetes Mellitus (T2DM)
Carmot Therapeutics, Inc. 447